時間 | 主題 | |||
---|---|---|---|---|
18:30 ~ 19:00 |
Registration |
|||
19:00 ~ 19:15 |
Opening
講者:
王弘仁
|
王弘仁 |
||
A New Era in La/mUC: How EV302 Transforms First-Line Therapy for Urothelial Cancer
講者:
Ignacio Durán
座長:
吳俊德
|
Ignacio Durán |
吳俊德 |
||
19:55 ~ 20:10 |
Q&A
講者:
All
座長:
吳俊德
|
All |
吳俊德 |
|
Unveiling EV+P's potential: EV-302 Asian Subgroup and Real-World Outcome in CGMH-KH
講者:
劉惠瑛
座長:
羅浩倫
|
劉惠瑛 |
羅浩倫 |
||
20:25 ~ 20:40 |
Navigating Skin Reactions: Effective Management Strategies for EV+P treatment
講者:
陳俊賓
座長:
蘇柏榮
|
陳俊賓 |
蘇柏榮 |
|
20:40 ~ 20:55 |
Panel Discussion
講者:
All
座長:
查岱龍
|
All |
查岱龍 |
|
20:55 ~ 21:00 |
Closing
講者:
查岱龍
|
查岱龍 |
時間 | 主題 | |||
---|---|---|---|---|
08:50 ~ 09:00 |
Opening
講者:
查岱龍
|
查岱龍 |
||
Emerging Roles of PSMA Based Diagnostics and Therapeutics in Prostate Cancer
講者:
Raj Tiwari
座長:
林威宇, 張兆祥, 張英勛 |
Raj Tiwari |
林威宇, 張兆祥, 張英勛 |
||
Digital Pathology with Prostate Cancer
講者:
Hong Koo Ha
座長:
林威宇, 張兆祥, 張英勛 |
Hong Koo Ha |
林威宇, 張兆祥, 張英勛 |
||
Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer & Real-World Experience of Using Generic Abiraterone
講者:
Pongwut Danchaivijitr
座長:
林威宇, 張兆祥, 張英勛 |
Pongwut Danchaivijitr |
林威宇, 張兆祥, 張英勛 |
||
10:10 ~ 10:20 |
Panel Discussion
講者:
All
座長:
吳文正
|
All |
吳文正 |
|
EV302 Unveiled: Revolutionize the Future of 1L LA/mUC Treatemnt
講者:
Ignacio Durán
座長:
蔡曜州, 黃昭淵, Sun Il KIM |
Ignacio Durán |
蔡曜州, 黃昭淵, Sun Il KIM |
||
Perioperative Durvalumab with Neoadjuvant Chemotherapy in MIBC
講者:
Tae-Hwan Kim
座長:
蔡曜州, 黃昭淵, Sun Il KIM |
Tae-Hwan Kim |
蔡曜州, 黃昭淵, Sun Il KIM |
||
The Role of Antibody-conjugate Drugs in Genitourinary Cancer Management : Current Status
講者:
Lukman Hakim
座長:
蔡曜州, 黃昭淵, Sun Il KIM |
Lukman Hakim |
蔡曜州, 黃昭淵, Sun Il KIM |
||
11:30 ~ 11:50 |
Panel Discussion
講者:
All
座長:
余家政
|
All |
余家政 |